These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9517377)

  • 41. Flavonoids as CYP3A4 Inhibitors In Vitro.
    Kondža M; Brizić I; Jokić S
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trainable structure-activity relationship model for virtual screening of CYP3A4 inhibition.
    Didziapetris R; Dapkunas J; Sazonovas A; Japertas P
    J Comput Aided Mol Des; 2010 Nov; 24(11):891-906. PubMed ID: 20814717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complementary and alternative medicine use by osteoporosis clinic patients.
    Chong CA; Diaz-Granados N; Hawker GA; Jamal S; Josse RG; Cheung AM
    Osteoporos Int; 2007 Nov; 18(11):1547-56. PubMed ID: 17603742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of ipriflavone and its main metabolites on theophylline biotransformation.
    Monostory K; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1996; 21(1):61-6. PubMed ID: 8839679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
    Kim KA; Lee JS; Park HJ; Kim JW; Kim CJ; Shim IS; Kim NJ; Han SM; Lim S
    Life Sci; 2004 Apr; 74(22):2769-79. PubMed ID: 15043991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
    Kim KA; Park JY
    Drug Metab Dispos; 2003 Sep; 31(9):1090-2. PubMed ID: 12920163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.
    Fischer V; Johanson L; Heitz F; Tullman R; Graham E; Baldeck JP; Robinson WT
    Drug Metab Dispos; 1999 Mar; 27(3):410-6. PubMed ID: 10064574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ipriflavone as an inhibitor of human cytochrome P450 enzymes.
    Monostory K; Vereczkey L; Lévai F; Szatmári I
    Br J Pharmacol; 1998 Feb; 123(4):605-10. PubMed ID: 9517377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The ipriflavone story].
    György L; Mihály N; Marian EP; István H
    Acta Pharm Hung; 1995 Nov; 65(6):191-4. PubMed ID: 8742624
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.